Successful treatment of chromoblastomycosis with 5-fluorocytosine.
D000284:Administration, Oral; D000287:Administration, Topical; D000293:Adolescent; D000935:Antifungal Agents / Q000627:therapeutic use*; D001681:Biological Assay; D001706:Biopsy; D002175:Candida; D002862:Chromoblastomycosis / Q000188:drug therapy*; D003596:Cytosine / Q000627:therapeutic use*; D004641:Emigration and Immigration; D005437:Flucytosine / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D006801:Humans; D007958:Leukocyte Count; D007962:Leukocytes / Q000187:drug effects; D008297:Male; D008826:Microbial Sensitivity Tests; D010676:Phialophora / Q000302:isolation & purification; D011537:Pruritus / Q000188:drug therapy
D000935:Antifungal Agents; D003596:Cytosine; D005437:Flucytosine